A Correlation between Dyslipidaemia and Glycaemic Control in Type 2 Diabetic Patients
Profile of Drowning Autopsies at Rajkot Civil Hospital
DOI:
https://doi.org/10.70284/njirm.v3i1.1965Keywords:
dyslipidaemia, type-2 diabetics, glycaemic control, HbA1c levelAbstract
Background: Diabetes is global endemic with rapidly increasing prevalence in both developing and
developed countries. There is a high risk of cardiovascular diseases in people with type 2 diabetes, while
Abnormal lipid profiles and lipoprotein oxidation (especially LDL-C) are more common in diabetics and are
aggravated with poor glycaemic control. The aim of the present study is to assess the glycaemic control status
by HbA1c estimation and to compare the lipid profile in type 2 diabetes patients with good glycaemic control
(HbA1c≤8) & those with poor glycaemic control (HbA1c>8). Materials and methods: The present study was
conducted on 100 type-2 diabetic males aged 40-60 years. Among them 48 patients having HbA1c level ≤8%
were categorized as having good glycaemic control (group-1)and 52 patients with HbA1c >8% were
categorized as having poor glycaemic control(group-2). Result: A significant increase in
S.cholesterol(254.46±45.54), s.LDL(162.57±39.79), S.VLDL(45.98±14.69) and S.triglycerides (225. ±76.61) in
group-2 pateints (P≤0.05) were noticed as compare to group-1 patients. Our findings suggest positive
association between dyslipidemia and glycemic control on the basis of screening with the HbA1c level. Raised
triglyceride and LDL levels are established risk factors for coronary artery diseases. Conclusion: The optimal
care of diabetic patients should also include periodic screening for lipid abnormalities and periodic
measurement of HbA1C for glycaemic control.
References
patients with diabetes:part 1:recent advance in
prevention and noninvasive management. J Am
Coll Cardiol 49:631-642
2. Taskinen MR. Diabetic Dyslipidemia;
Atheroscler Suppl. 2002 May;3(1):47-5
3. Evans M, Khan N, Rees A. Diabetic
dyslipidaemia and coronary heart disease: new
perspectives. Curr Opin Lipidol 1999;10:387-
391.
4. Bennett PH (2000). Epidemiology of type 2
diabetes mellitus: 2000 Sep;23(9):1249-54
5. Sajjadi F, Mohammadifard N, Ghaderian N,
Alikhasi H, Maghroon M (2005 ). Clustering of
cardiovascular risk factors in diabetic and IGT
cases in Isfahan province. 2000 – 2001: Isfan
healthy heart program. ARYA .J. 1(2): 94-100
6. Manu A, Shyamal K, Sunil G, Sandhu J S (2007).
A study on lipid profile and body fat in patients
with diabetes mellitus. Anthropologist. (4): 295
– 298.
7. Ronald M. krauss. Lipid & Lipoproteins in
patients with type 2 diabetes. ADA:Diabetes
care.june2004:vol(27)no-6:1496-1504
8. Austin MA, Edwards KL. Small, dense low
density lipoproteins, the insulin resistance
syndrome and non insulin-dependent diabetes.
Curr Opin Lipidol 1996; 7:167-171
9. Tietz clinical chemistry and molecular
diagnostics 4th ed: 879-883
10. Hassed Ahmed khan . “Clinical significance of
HbA1c as a marker of circulating lipid in male
and female type 2 diabetic patients.â€Acta –
Diabetol. 2007 Dec;44(4):193-200.
11. Waqar Ahmed,Abdul Rehman Arshad.Effect of
glycemic control on diabetes
dyslipidemia,Pakistan armed force medical
journal march 2010 issue no:1
12. Muhammad Saidullah,Ardhan Sarkar et al:
“Comparison of lipid profile between controlled
and uncontrolled Diabetic subjects.Bangladesh J
Path 25(1):10
13. Syes S. Habib ,Mohammad Aslam: Risk
factor,knowledge and health status in diabetic
patients.Saudi medical journal,2003;vol-
24(11):1219-1224
14. Lipid Research Clinical Program (1984). The
lipid Research Clinic Coronary Primary
prevention trial results II. J. AM. Med. Assoc.
251: 364 – 374
